Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment, By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region

  • ID: 4586484
  • Report
  • Region: Global, Indonesia
  • 118 Pages
  • Ken Research Private Limited
1 of 4

FEATURED COMPANIES

  • Biofarma
  • Fahrenheit
  • PT Kalbe Farma
  • PT Merck Tbk
  • PT Sanbe Farma
  • PT Tempo Scan Pacific Tbk
  • MORE

The report titled ""Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region"" provides information on market size for Indonesia Healthcare and pharmaceutical. The report covers aspects such as healthcare market segment (by hospitals, pharmaceuticals, medical devices and clinical laboratory), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), competitive landscape of major players in the Indonesia pharmaceutical market, and covering competitive landscape of major pharmaceutical companies including PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific Tbk, PT Merck Tbk, Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biofarma
  • Fahrenheit
  • PT Kalbe Farma
  • PT Merck Tbk
  • PT Sanbe Farma
  • PT Tempo Scan Pacific Tbk
  • MORE

1. Executive Summary

  • Indonesia Healthcare Market Overview
  • Indonesia Pharmaceutical Market Segmentation
  • Indonesia Pharmaceutical Market Competition Overview
  • Indonesia Pharmaceutical Market Future Potential

2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling

  • Consolidated Research Approach
  • Market Sizing – Pharmaceutical Market
  • Variables (Dependent and Independent)
  • Multi Factor Based Sensitivity Model
  • Final Conclusion

3. Indonesia Healthcare Market Size, 2012-2017

4. Indonesia Pharmaceutical Market Introduction
4.1. Indonesia Pharmaceutical Market Size, 2012-2017

5. Indonesia Pharmaceutical Market Segmentation, 2017
5.1. By Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2015 & 2017
Vitamins and Dietary Supplements Market, 2012-2017
5.2. By Domestic and International Players, 2012-2017
5.3. By Generic and Patented Drug, 2017
By Type of Generic Drugs (Unbranded, Ethical and Free Sales), 2013 and 2017
5.4. By OTC and Prescription Drugs, 2012-2017
5.5. By Domestic Sales and Exports, 2012-2016
5.6. By Region (West Java, East Java, Central Java, Jakarta and Others), Dec 2016

6. Trends, Developments and Restraint in Indonesia Pharmaceutical Market

  • Growth in Indonesia Animal Pharmaceutical and Vaccine Market
  • Increased Government Support
  • Rise in Mergers and Acquisitions Activities
  • Growing Investment from Foreign Companies
  • Dependence on Imports for API (Active Pharmaceutical ingredient) Procurement
  • Other Challenges Faced

7. Government Regulations for Indonesia Pharmaceutical market

  • Pharmaceutical Finished Products Registration Requirement
  • Registration Procedure
  • Pharmaceutical Raw Materials
  • Advertising and Distribution
  • FDI in Pharmaceutical Industry
  • Procedure of Applying for Patent in Indonesia
  • Import Regulations
  • Draft Law on Monitoring of Pharmaceutical Supply, Medical Devices and Household Health Products
  • Draft law on Hala Product Guarantee
  • Regulations for Non-Indonesian Stakeholders Planning to Enter the Pharmaceutical Market

8. Indonesia Biopharmaceutical Industry Snapshot

  • Innogene Kalbiotech

9. Snapshot on Indonesia Vaccine Market

10. Competitive Scenario for Major Players in Indonesia Pharmaceutical Market
10.1. Market Share of Major Players in Indonesia Pharmaceutical Market, 2015

11. Competitive Landscape of Major Players in Indonesia Pharmaceutical Market
11.1. PT Kalbe Farma
Product Portfolio for PT Kalbe Farma
11.2. PT Sanbe Farma
Product Portfolio for PT Sanbe Farma
11.3. PT SOHO Global Health
11.4. PT Dexa Medica
Product Portfolio for Dexa Medica
11.5. PT Pharos
Product Portfolio for PT Pharos
11.6. PT Kimia Farma
Product Portfolio for PT Kimia Farma
11.7. PT Tempo Scan Pacific Tbk
Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
11.8. PT Merck Tbk
11.9. Overview for Other Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market

12. Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
12.1. By Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2022
12.2. By Generic and Patent Drugs, 2022

13. Analyst Recommendations

14. Macro Economic Factors Affecting Indonesia Healthcare Market
14.1. Population, 2012-2022
14.2. Number of Health Centers, 2012-2022
14.3. Budget Allocation on Healthcare, 2012-2022
14.4. Obese Population, 2012-2022

Disclaimer

Contact Us

List of Figures

Figure 1-1: Indonesia Pharmaceutical Market Flowchart
Figure 3-1: Indonesia Healthcare Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 4-1: Indonesia Pharmaceutical Market Size on the Basis of Revenue in USD Billion and Growth Rate in Percentage (%), 2012-2017
Figure 5-1: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in Percentage (%), 2017
Figure 5-2: Indonesia Vitamin and Dietary Supplements Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 5-3: Indonesia Vitamin and Dietary Supplements Market Segmentation by Distribution Channel on the Basis of Revenue in Percentage (%), 2017
Figure 5-4: Market Share of Major Companies in Indonesia Vitamin and Dietary Supplements Market on the Basis of Revenue in Percentage (%), 2017
Figure 5-5: Indonesia Pharmaceutical Market Segmentation by Domestic and International Players on the Basis of Revenue in Percentage (%), 2012-2017
Figure 5-6: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Revenue in Percentage (%), 2017
Figure 5-7: Indonesia Generic Drug Market Segmentation by Type (Unbranded, Ethical and Free Sales) on the Basis of Revenue in Percentage (%), 2017
Figure 5-8: Indonesia Pharmaceutical Market Segmentation by OTC and Prescription Drugs on the Basis of Revenue in Percentage (%), 2012-2017
Figure 5-9: Indonesia Pharmaceutical Market Segmentation by Domestic Sales and Exports on the Basis of Revenue in Percentage (%), 2012-2016
Figure 5-10: Indonesia Pharmaceutical Market Segmentation by Region (West Java, East Java, Central Java, Jakarta and Others) on the Basis of Number of Companies in Percentage (%), as of Dec 2016
Figure 6-1: Indonesia Animal Pharmaceutical and Vaccine Market Size on the Basis of Revenue in USD Million, 2012-2017
Figure 7-1: Process of Establishing a Pharmaceutical Company in Indonesia
Figure 9-1: Indonesia Pharmaceutical Market Segmentation on the Basis of Vaccine and Other Pharmaceutical Drugs on the Basis of Revenue in Percentage (%), 2017
Figure 10-1: Indonesia Pharmaceutical Market Share of Major Players on the Basis of Revenue in Percentage (%), 2015
Figure 12-1: Indonesia Pharmaceutical Market Future Projections on the Basis of Revenue in USD Billion, 2018-2022
Figure 12-2: Indonesia Pharmaceutical Market Future Outlook and Projections by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in Percentage (%), 2022
Figure 12-3: Indonesia Pharmaceutical Market Future Projections by Generic and Patent Drugs on the Basis of Revenue in Percentage (%), 2022
Figure 14-1: Population of Indonesia in Million, 2012-2022
Figure 14-2: Number of Health Centers in Indonesia, 2012-2022
Figure 14-3: Budget Allocation on Healthcare in Indonesia in IDR Trillion, 2012-2022
Figure 14-4: Obese Population in Indonesia in Million, 2012-2022

List of Tables

Table 2-1: Therapeutic Segments Covered in Indonesia Pharmaceutical Market
Table 2-2: Correlation Matrix for Indonesia Healthcare Market
Table 2-3: Regression Coefficients Output
Table 3-1: Key Developments in Indonesia Healthcare Market, 2012-2017
Table 3-2: Change in Foreign Investment Regulation in Different Healthcare Verticals in Indonesia
Table 4-1: Introduction for Indonesia Pharmaceutical Industry
Table 4-2: Key Developments in Indonesia Pharmaceutical Market, 2012-2017
Table 5-1: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in USD Million, 2015 and 2017
Table 5-2: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Best Selling Medicines, major Companies and OTC and Prescribed
Table 5-3: Indonesia Vitamin and Dietary Supplements Market Segmentation by Distribution Channel on the Basis of Revenue in USD Million, 2017
Table 5-4: Market Share of Major Companies in Indonesia Vitamin and Dietary Supplements Market on the Basis of Revenue in USD Million, 2012-2017
Table 5-5: Indonesia Pharmaceutical Market Segmentation by Domestic and International Players on the Basis of Revenue in USD Billion, 2012-2017
Table 5-6: Key Takeaways for Indonesia Pharmaceutical Market Segmentation by Domestic and International Players
Table 5-7: Major Therapeutic Segments for Domestic and International Companies
Table 5-8: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Revenue in USD Billion, 2017
Table 5-9: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Best Selling Medicines, Major Companies and Therapeutic Class
Table 5-10: Indonesia Generic Drug Market Segmentation by Type (Unbranded, Ethical and Free Sales) on the Basis of Revenue in USD Billion, 2013 and 2017
Table 5-11: Indonesia Pharmaceutical Market Segmentation by OTC and Prescription Drugs on the Basis of Revenue in USD Billion, 2012-2017
Table 5-12: Indonesia Pharmaceutical Market Segmentation by Domestic Sales and Exports on the Basis of Revenue in USD Million, 2012-2016
Table 5-13: Indonesia Pharmaceutical Products Export by Value in USD Thousand, 2014-2016
Table 5-14: Indonesia Pharmaceutical Market Segmentation by Region (West Java, East Java, Central Java, Jakarta and Others) on the Basis of Number of Companies, as of Dec 2016
Table 6-1: Major Mergers, Acquisitions and Joint Ventures in Indonesia Pharmaceutical Industry during 2012-2017
Table 6-2: Major Alliances in Indonesia Pharmaceutical Industry
Table 7-1: Registration of Finished Pharmaceutical Products in Indonesia
Table 7-2: Procedure for Applying for Patent in Indonesia.
Table 8-1: Snapshot for Indonesia Biopharmaceutical Industry
Table 8-2: Competitive Landscape of Innogene Kalbiotech including Overview, Products and Services, Partners and Business Strategies
Table 9-1: Indonesia Pharmaceutical Market Segmentation on the Basis of Vaccine and Other Pharmaceutical Drugs on the Basis of Revenue in USD Billion, 2017
Table 10-1: Competitive Parameters in Indonesia Pharmaceutical Market
Table 10-2: Rationale for Market Share of Major Players in Indonesia Pharmaceutical Market, 2015
Table 10-3: Market Share of Major Players in Indonesia Pharmaceutical Market on the Basis of Revenue in USD Million, 2015
Table 11-1: Competitive Landscape of PT Kalbe Farma including Company Overview, USP, Business Segments, Corporate Social Responsibility, Certifications and Accreditations, Manufacturing Plants, Business Strategies, Number of Employees, Best Selling products, New Product Launches and Recent Developments
Table 11-2: Market Share of Major Products of PT Kalbe Farma on the Basis of Volume in Percentage (%), 2016
Table 11-3: Manufacturing Facility of PT Kalbe Farma
Table 11-4: Product Portfolio for PT Kalbe Farma, Indonesia
Table 11-5: Competitive Landscape of PT Sanbe Farma including Company Overview, USP, Product Segments, Subsidiaries, Certifications and Accreditations, Plants, Future Strategies, Number of Employees and Distribution Network
Table 11-6: Product portfolio for PT Sanbe Farma, Indonesia
Table 11-7: Competitive Landscape of PT SOHO Global Health including Company Overview, USP, Product Segments, Subsidiaries, Certifications and Accreditations, Plants, Future Strategies, Number of Employees and Distribution Network
Table 11-8: Competitive Landscape of PT Dexa Medica including Company Overview, USP, Product Segments, Business Strategies, Estimate Revenue and Number of Employees
Table 11-9: Major Products Portfolio for PT Dexa Medica, Indonesia
Table 11-10: Competitive Landscape of PT Pharos including Company Overview, USP, Product Segments, Business Strategies and Number of Employees
Table 11-11: product Portfolio for PT Pharos, Indonesia
Table 11-12: Competitive Landscape of PT Kimia Farma including Company Overview, Strength, Product Segments, Business Strategies and Number of Employees
Table 11-13: Type of Products manufactured at Different Manufacturing Facilities of Kimia Farma, Indonesia
Table 11-14: Major Products Portfolio for PT Kimia Farma, Indonesia
Table 11-15: Competitive Landscape of PT Tempo Scan Pacific Tbk including Company Overview, USP, Product Line, Business Division, Distribution Network, Corporate Social Responsibility, Business Strategies and Number of Employees
Table 11-16: Manufacturing Facility for PT Tempo Scan Pacific Tbk, Indonesia
Table 11-17: Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
Table 11-18: Competitive Landscape for PT Merck Tbk including Company Overview, Business Segments, Key Stats, Best Selling products and Business Strategy
Table 11-19: Key products in Biopharma Division for Merck Indonesia on the Basis of Therapeutic Segment
Table 11-20: Key products in Consumer Health Division for Merck Indonesia on the Basis of Therapeutic Segment
Table 11-21: Overview of Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market
Table 12-1: Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
Table 12-2: Indonesia Pharmaceutical Market Future Outlook and Projections by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in USD Billion, 2022
Table 12-3: Indonesia Pharmaceutical Market Future Outlook and Projections by Generic and Patent Drugs on the Basis of Revenue in USD Billion, 2022
Table 13-1: Analyst Recommendation for Indonesia Pharmaceutical Market
Table 14-1: Key Developments in Population of Indonesia, 2012-2022
Table 14-2: Key Developments in Number of Health Centers in Indonesia, 2012-2022
Table 14-3: Key Developments in Budget Allocation on Healthcare in Indonesia, 2012-2022
Table 14-4: Key Developments in Obese Population in Indonesia, 2012-2022

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Biofarma
  • Darya Varia and Konimex
  • Fahrenheit
  • PT Dexa Medica
  • PT Kalbe Farma
  • PT Kimia Farma
  • PT Merck Tbk
  • PT Pharos
  • PT Sanbe Farma
  • PT SOHO Global Health
  • PT Tempo Scan Pacific Tbk
  • PT. Novell Pharmaceutical Laboratories
  • Sanofi Aventis
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll